AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

AIDSinfo Releases HIV/AIDS Guidelines App for iOS and Android Devices
AIDSinfo is pleased to introduce HIV providers and other health professionals to our newly released HIV/AIDS Guidelines app! The AIDSinfo Guidelines app provides mobile access to the federally approved HIV/AIDS medical practice treatment guidelines. The guidelines include recommendations approved by expert panels on the treatment of HIV infection and related opportunistic infections in adults, adolescents, and children and on the management of perinatal HIV infection. Health care providers surveyed on the AIDSinfo website expect mobile access to up-to-date HIV information at the point of care—even when an Internet c...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - January 15, 2016 Category: Infectious Diseases Source Type: news

Recent HIV/AIDS News from FDA and NIAID
From FDA: December 21, 2015: FDA Updates Blood Donor Deferral Policy to Reflect the Most Current Scientific Evidence and Continue to Ensure the Safety of the U.S. Blood Supply December 21, 2015: Final Guidance: “Revised Recommendations for Reducing the Risk of Human Immunodeficiency Virus Transmission by Blood and Blood Products” From NIAID: December 23, 2015: HIV Antibody Infusion Safely Suppresses Virus in Infected People (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - January 8, 2016 Category: Infectious Diseases Source Type: news

FDA Updates Saquinavir Labeling
“FDA approved changes to the Invirase (saquinavir mesylate) label to provide update[s] for drugs that are contraindicated or interact with Invirase/ritonavir." “Also a warning was added to state cobicistat is not recommended for concomitant use with Invirase.” The updated labeling will be available at the FDA website. More information is available: FDA: Press release AIDSinfo: Patient fact sheet on saquinavir (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - January 8, 2016 Category: Infectious Diseases Source Type: news

Community Member Nominations are Now Being Accepted for the Department of Health and Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and Adolescents
The HHS Panel on Antiretroviral Guidelines for Adults and Adolescents (or the Panel) is accepting nominations for a new community representative to serve a 4-year term beginning April 2016 with potential for reappointment for one additional term. Individuals who served as Panel members in the past are welcome to reapply. The Panel welcomes diversified representation in the community membership reflecting the demographics of the current HIV epidemic in the United States. The community member may assist the Panel in identifying and addressing unique treatment aspects that relate to the constituency he/she represents. The can...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - January 8, 2016 Category: Infectious Diseases Source Type: news

Scientific/Clinical Member Nominations are Now Being Accepted for the Department of Health and Human Services (HHS) Panel on Antiretroviral Guidelines for Adults and Adolescents
The HHS Panel on Antiretroviral Guidelines for Adults and Adolescents (or the Panel) is accepting nominations for new scientific/clinical members with expertise in HIV medicine. The Panel is seeking candidates with expertise in any of the following areas of HIV clinical research and clinical care: adolescent medicine, biostatistics, HIV drug resistance, and hepatitis coinfection. Individuals who served as Panel members in the past are welcome to reapply. Panel members critically evaluate new information and prepare guidelines revisions. The candidates should be recognized experts in their areas of interest. The successf...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - January 8, 2016 Category: Infectious Diseases Source Type: news

Recent HIV/AIDS News from CDC
December 7, 2015: New CDC Efforts Offer Individuals Vital Information to Reduce Personal HIV Risk December 6, 2015: HIV Diagnoses Decline Almost 20 Percent, but Progress Is Uneven December 6, 2015: Southern States Lag Behind Rest of Nation in HIV Treatment, Testing   (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - December 18, 2015 Category: Infectious Diseases Source Type: news

Updates to the Mucocutaneous Candidiasis and Syphilis Sections of the Adult and Adolescent OI Guidelines
Discussion of management of patients with sexual risk history is expanded in terms of diagnostic and therapeutic approaches. Recommendations for the diagnosis and management of neurosyphilis and ocular syphilis have been more extensively delineated. Updated recommendations for treatment and retreatment options for syphilis in non-pregnant and pregnant persons are also provided. (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - December 18, 2015 Category: Infectious Diseases Source Type: news

Recent HIV/AIDS News from CDC and NIAID
From CDC: November 24, 2015: New CDC Estimates Underscore the Need to Increase Awareness of a Daily Pill That Can Prevent HIV Infection From NIAID: December 1, 2015: NIH Scientists Draw Evidence-Based Blueprint for HIV Treatment and Prevention November 25, 2015: NIH Publishes Criteria for Research on Organ Transplantation Between People with HIV Infection (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS))
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - December 4, 2015 Category: Infectious Diseases Source Type: news

OAR Develops FY 2016 Trans-NIH Plan for HIV-Related Research
Each year the NIH Office of AIDS Research (OAR) develops a Trans-NIH Plan for HIV-Related Research. The plan identifies overarching HIV/AIDS research priorities and specific research objectives. The following key scientific priorities shape the FY 2016 Trans-NIH Plan for HIV-Related Research: Prevention research Research toward a cure Optimization of therapeutics Coinfections, comorbidities, and complications Basic research To learn more, visit the OAR website. (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S....
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - December 4, 2015 Category: Infectious Diseases Source Type: news

Adult and Adolescent ARV Guidelines: Survey
Do you utilize the HIV treatment guidelines? Your opinion is valuable! The Panel on Antiretroviral Guidelines for Adults and Adolescents and the Health Resources and Services Administration (HRSA) HIV/AIDS Bureau (HAB) is committed to improving the Department of Health and Human Services (HHS) Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. HAB has launched a survey (OMB clearance number 1090-0007) to receive feedback on experiences with the guidelines. The survey is open until December 18, 2015. The survey takes less than 15 minutes to complete, and all responses will remain ...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - December 4, 2015 Category: Infectious Diseases Source Type: news

NIH Launches Initiative to Develop Long-Acting HIV Treatment and Prevention Tools
"The National Institute of Allergy and Infectious Diseases (NIAID), part of the National Institutes of Health, launched a major initiative to advance novel approaches to treat and prevent HIV infections based on broadly neutralizing antibodies (bNAbs) today. A public-private partnership has been established for this effort between NIAID and the global pharmaceutical company GlaxoSmithKline (GSK) to enable researchers to develop one or more bNAbs, which can stop a wide range of HIV strains from infecting human cells in the laboratory, into a product to treat or prevent HIV infection."   For more information, view the N...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - November 20, 2015 Category: Infectious Diseases Source Type: news

December 1 is World AIDS Day
December 1 is recognized globally as World AIDS Day. The annual observance highlights the remarkable advances in HIV prevention, treatment, and care since what became known as the AIDS epidemic was first reported three decades ago. World AIDS Day is also an occasion to reflect on the ongoing challenges to achieve an AIDS-free generation. Visit our World AIDS Day webpage [en español] to learn more about this observance and to find HIV/AIDS-related information and resources. (Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health a...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - November 20, 2015 Category: Infectious Diseases Source Type: news

HRSA Launches Survey on Adult and Adolescent ARV Guidelines
The Panel on Antiretroviral Guidelines for Adults and Adolescents and the Health Resources and Services Administration (HRSA) HIV/AIDS Bureau (HAB) is committed to improving the Department of Health and Human Services (HHS) Guidelines for the Use of Antiretroviral Agents in HIV-1-Infected Adults and Adolescents. HAB has launched a survey to receive feedback on experiences with the guidelines. The target audience are those staff that utilize the HIV treatment guidelines such as physicians, nurses, physician assistants (PAs), etc. It takes less than 15 minutes to complete the survey, and all responses will remain anonymous. ...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - November 20, 2015 Category: Infectious Diseases Source Type: news

Elvitegravir/Cobicistat/Emtricitabine/Tenofovir Alafenamide Now Included Among Recommended Regimens for Antiretroviral Treatment-Naive Individuals with HIV-1 Infection
The FDA recently approved the fixed-dose combination of elvitegravir, cobicistat, emtricitabine, and tenofovir alafenamide (EVG/c/FTC/TAF) as a complete regimen for antiretroviral treatment (ART)-naive HIV-infected individuals 12 years or older. Based on efficacy and safety data from phase 3 randomized clinical trials, the HHS Panel on Antiretroviral Guidelines for Adults and Adolescents will include EVG/c/FTC/TAF among the Recommended Initial Regimens for ART-naive adults and adolescents with estimated creatinine clearance ≥ 30 mL/min (AI). For more information, see the Panel’s statement on EVG/c/FTC/TAF. (Source...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - November 20, 2015 Category: Infectious Diseases Source Type: news

FDA Announces Final Guidance: HIV-1 Infection: Developing Antiretroviral Drugs for Treatment: Guidance for Industry
FDA is announcing final guidance titled “Human Immunodeficiency Virus-1 Infection: Developing Antiretroviral Drugs for Treatment: Guidance for Industry.”   This guidance provides recommendations for the development of antiretroviral drugs regulated within the Center for Drug Evaluation and Research at the FDA for the treatment of human immunodeficiency virus-1 (HIV-1 or HIV) infection. Specifically, this guidance addresses the FDA’s current thinking regarding the overall development program and clinical trial designs for antiretroviral drugs to support an indication for the treatment of HIV-1 infecti...
Source: AIDSinfo At-a-Glance: Offering Information on HIV/AIDS Treatment, Prevention, and Research, A Service of the U.S. Department of Health and Human Services (DHHS) - November 6, 2015 Category: Infectious Diseases Source Type: news